Literature DB >> 13680163

Acute effects of megestrol on the hypothalamic-pituitary-adrenal axis.

Thomas J Raedler1, Holger Jahn, Birgit Goedeken, Dorothee M Gescher, Michael Kellner, Klaus Wiedemann.   

Abstract

BACKGROUND: Clinical observations suggest that prolonged treatment with megestrol can lead to Cushing-like symptoms, while withdrawal of prolonged treatment with megestrol may result in adrenal insufficiency. However, only little is known about the acute effects of megestrol on the hypothalamic-pituitary-adrenal (HPA) axis. As part of an endocrine study, we evaluated the acute effects of megestrol, hydrocortisone and placebo on morning cortisol and ACTH levels.
METHOD: . Using a balanced double-blind design, ten healthy male subjects were treated at 11:00 p.m. and 8:00 a.m. with megestrol (total dose 320 mg), hydrocortisone (total dose 30 mg) or placebo. After 1 h of rest, blood was drawn at 10:00 a.m. and 10:30 a.m. for determination of cortisol and ACTH levels.
RESULTS: . Compared to placebo, acute administration of megestrol resulted in a significant decrease in morning ACTH and cortisol levels. The suppression of ACTH after pretreatment with megestrol was less pronounced than after pretreatment with hydrocortisone.
CONCLUSIONS: Our results suggest that megestrol exerts glucocorticoid-like effects and has an acute depressing effect on the HPA axis. Therefore alterations in the steroid system should be included in the differential diagnosis of all subjects under treatment with megestrol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680163     DOI: 10.1007/s00280-003-0697-6

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  2 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  A Prospective Multicenter Study Evaluating Secondary Adrenal Suppression After Antiemetic Dexamethasone Therapy in Cancer Patients Receiving Chemotherapy: A Korean South West Oncology Group Study.

Authors:  Hye Sook Han; Ji Chan Park; Suk Young Park; Kyu Taek Lee; Sang Byung Bae; Han Jo Kim; Samyoung Kim; Hwan Jung Yun; Woo Kyun Bae; Hyun-Jeong Shim; Jun-Eul Hwang; Sang-Hee Cho; Moo-Rim Park; Hyeok Shim; Jihyun Kwon; Moon Ki Choi; Seung Taik Kim; Ki Hyeong Lee
Journal:  Oncologist       Date:  2015-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.